{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:34:48Z","timestamp":1790836488209,"version":"4.1.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1200204"],"award-info":[{"award-number":["2017YFC1200204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFD0400300"],"award-info":[{"award-number":["2017YFD0400300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hepatitis B virus (HBV) can hijack the host bile acids (BAs) metabolic pathway during infection in cell and animal models. Additionally, microbiome was known to play critical role in the enterohepatic cycle of BAs. However, the impact of HBV infection and associated gut microbiota on the BA metabolism in chronic hepatitis B (CHB) patients is unknown. This study aimed to unveil the distinct BA profiles in chronic HBV infection (CHB) patients with no or mild hepatic injury, and to explore the relationship between HBV, microbiome and BA metabolism with clinical implications.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Serum BA profiles were compared between CHB patients with normal ALT (CHB-NALT, <jats:italic>n<\/jats:italic> = 92), with abnormal ALT (CHB-AALT, <jats:italic>n<\/jats:italic> = 34) and healthy controls (HCs, <jats:italic>n<\/jats:italic> = 28) using UPLC-MS measurement. Hepatic gene expression in CHB patients were explored using previously published transcriptomic data. Fecal microbiome was compared between 30 CHB-NALT and 30 HCs using 16S rRNA sequencing, and key microbial function was predicted by PICRUSt analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Significant higher percentage of conjugated BAs and primary BAs was found in CHB patients even without apparent liver injury. Combinatory BA features can discriminate CHB patients and HCs with high accuracy (AUC = 0.838). Up-regulation of BA importer Na+ taurocholate co-transporting peptide (NTCP) and down-regulation of bile salt export pump (BSEP) was found in CHB-NALT patients. The microbial diversity and abundance of <jats:italic>Lactobacillus, Clostridium, Bifidobacterium<\/jats:italic> were lower in CHB-NALT patients compared to healthy controls. Suppressed microbial bile salt hydrolases (BSH), 7-alpha-hydroxysteroid dehydrogenase (hdhA) and 3-dehydro-bile acid Delta 4, 6-reductase (BaiN) activity were found in CHB-NALT patients.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study provides new insight into the BA metabolism influenced both by HBV infection and associated gut microbiome modulations, and may lead to novel strategy for clinical management for chronic HBV infection.<\/jats:p>","DOI":"10.3389\/fmed.2021.708495","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T04:47:59Z","timestamp":1633322879000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome"],"prefix":"10.3389","volume":"8","author":[{"given":"Zeyu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kundan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenggang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"G801","DOI":"10.1152\/ajpgi.1995.269.6.G801","article-title":"Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile","volume":"269","author":"Meier","year":"1995","journal-title":"Am J Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/hep.27608","article-title":"The pSer267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B","volume":"61","author":"Peng","year":"2015","journal-title":"Hepatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1128\/JVI.03478-13","article-title":"Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide","volume":"88","author":"Yan","year":"2014","journal-title":"J Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.27159","article-title":"Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism","volume":"60","author":"Oehler","year":"2014","journal-title":"Hepatology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1096\/fj.201801181R","article-title":"Farnesoid X receptor-alpha is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo","volume":"33","author":"Mouzannar","year":"2019","journal-title":"FASEB J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1096\/fj.201500134","article-title":"Reciprocal regulation of farnesoid X receptor alpha activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes","volume":"30","author":"Radreau","year":"2016","journal-title":"FASEB J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"42549","DOI":"10.1074\/jbc.M107557200","article-title":"Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor","volume":"276","author":"Song","year":"2001","journal-title":"J Biol Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/S0016-5085(03)00388-3","article-title":"FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity","volume":"124","author":"Barbier","year":"2003","journal-title":"Gastroenterology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1194\/jlr.M039404","article-title":"Regulation of human class I alcohol dehydrogenases by bile acids","volume":"54","author":"Langhi","year":"2013","journal-title":"J Lipid Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00008571-200410000-00001","article-title":"Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene","volume":"14","author":"Gnerre","year":"2004","journal-title":"Pharmacogenetics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/JCI18945","article-title":"Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis","volume":"112","author":"Liu","year":"2003","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/sj.emboj.7600728","article-title":"Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP","volume":"24","author":"Boulias","year":"2005","journal-title":"EMBO J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol Cell."},{"key":"B19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbrc.2004.07.102","article-title":"Interleukin-6 regulates hepatic transporters during acute-phase response","volume":"322","author":"Siewert","year":"2004","journal-title":"Biochem Biophys Res Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"31416","DOI":"10.1074\/jbc.M204818200","article-title":"Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the ntcp promoter is JNK-dependent","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab Dispos."},{"key":"B22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fmed.2017.00163","article-title":"Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts","volume":"4","author":"Urdaneta","year":"2017","journal-title":"Front Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J Lipid Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nchembio.1864","article-title":"biosynthetic pathway for a prominent class of microbiota-derived bile acids","volume":"11","author":"Devlin","year":"2015","journal-title":"Nat Chem Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00248-010-9801-8","article-title":"Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection","volume":"61","author":"Lu","year":"2011","journal-title":"Intestinal microbiota of HBV cirrhotic patients Microb Ecol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature."},{"key":"B27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","article-title":"Bile acids as regulatory molecules","volume":"50","author":"Hylemon","year":"2009","journal-title":"J Lipid Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","article-title":"Bile Acid metabolism and signaling in cholestasis, inflammation, and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1194\/jlr.D047506","article-title":"A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS","volume":"55","author":"Kakiyama","year":"2014","journal-title":"J Lipid Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/liv.13201","article-title":"Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis","volume":"37","author":"Horvatits","year":"2017","journal-title":"Liver Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/toxsci\/kfu228","article-title":"Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients","volume":"143","author":"Bathena","year":"2015","journal-title":"Toxicol Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e90780","DOI":"10.1172\/jci.insight.90780","article-title":"Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response","volume":"2","author":"Cai","year":"2017","journal-title":"JCI Insight."},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fmed.2020.00015","article-title":"Bile acid receptor therapeutics effects on chronic liver diseases","volume":"7","author":"Meadows","year":"2020","journal-title":"Front Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fmed.2020.00060","article-title":"Attenuation of the hepatoprotective effects of ileal apical sodium dependent bile acid transporter (asbt) inhibition in choline-deficient l-amino acid-defined (cdaa) diet-fed mice","volume":"7","author":"Rao","year":"2020","journal-title":"Front Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fmed.2020.00544","article-title":"Bile acids and FXR: novel targets for liver diseases","volume":"7","author":"Stofan","year":"2020","journal-title":"Front Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/liv.13427","article-title":"Predictive model for inflammation grades of chronic hepatitis B: large-scale analysis of clinical parameters and gene expressions","volume":"37","author":"Zhou","year":"2017","journal-title":"Liver Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat Biotechnol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.bbagen.2016.09.024","article-title":"Molecular features of bile salt hydrolases and relevance in human health","volume":"1861","author":"Chand","year":"2017","journal-title":"Biochim Biophys Acta."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e115175","DOI":"10.1371\/journal.pone.0115175","article-title":"Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes","volume":"9","author":"Labbe","year":"2014","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0005-2744(76)90068-1","article-title":"Purification and characterization of bile salt hydrolase from bacteroides fragilis subsp","volume":"452","author":"Stellwag","year":"1976","journal-title":"fragilis Biochim Biophys Acta"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch Intern Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/acs.jproteome.0c00852","article-title":"Bile acid profiles are distinct among patients with different etiologies of chronic liver disease","volume":"20","author":"Sang","year":"2021","journal-title":"J Proteome Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/apt.15035","article-title":"Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD","volume":"49","author":"Caussy","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/hep.23984","article-title":"Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: studies in Oatp1b2-null mice","volume":"53","author":"Csanaky","year":"2011","journal-title":"Hepatology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/hep.29251","article-title":"Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J Clin Invest."},{"key":"B52","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.1007\/s00216-015-8853-5","article-title":"Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel na(+)-taurocholate cotransporting polypeptide inhibitor","volume":"407","author":"Haag","year":"2015","journal-title":"Anal Bioanal Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut","volume":"111","author":"Joyce","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl Microbiol Biotechnol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3389\/fmicb.2017.02222","article-title":"Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis b patients","volume":"8","author":"Wang","year":"2017","journal-title":"Front Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jvh.13216","article-title":"Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma","volume":"27","author":"Zeng","year":"2020","journal-title":"J Viral Hepat."},{"key":"B57","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0005-2760(76)90086-2","article-title":"3alpha-, 7alpha- and 12alpha-hydroxysteroid dehydrogenase activities from clostridium perfringens","volume":"450","author":"Macdonald","year":"1976","journal-title":"Biochim Biophys Acta."},{"key":"B58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jsbmb.2011.08.002","article-title":"Hydroxysteroid dehydrogenases (HSDs) in bacteria: a bioinformatic perspective","volume":"129","author":"Kisiela","year":"2012","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1128\/jb.176.16.4865-4874.1994","article-title":"Characterization and regulation of the NADP-linked 7 alpha-hydroxysteroid dehydrogenase gene from clostridium sordellii","volume":"176","author":"Coleman","year":"1994","journal-title":"J Bacteriol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00253-011-3798-x","article-title":"In search of sustainable chemical processes: cloning, recombinant expression, and functional characterization of the 7alpha- and 7beta-hydroxysteroid dehydrogenases from clostridium absonum","volume":"95","author":"Ferrandi","year":"2012","journal-title":"Appl Microbiol Biotechnol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1194\/jlr.M020313","article-title":"Identification and characterization of two bile acid coenzyme A transferases from clostridium scindens, a bile acid 7alpha-dehydroxylating intestinal bacterium","volume":"53","author":"Ridlon","year":"2012","journal-title":"J Lipid Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1111\/jcmm.14951","article-title":"Modulation of bile acid profile by gut microbiota in chronic hepatitis B","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1194\/jlr.M075143","article-title":"Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents","volume":"58","author":"Watanabe","year":"2017","journal-title":"J Lipid Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00535-017-1400-8","article-title":"Immunoglobulin A and liver diseases","volume":"53","author":"Inamine","year":"2017","journal-title":"J Gastroenterol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"33093","DOI":"10.1038\/srep33093","article-title":"Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"M110004945","DOI":"10.1074\/mcp.M110.004945","article-title":"Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma","volume":"10","author":"Chen","year":"2011","journal-title":"Mol Cell Proteomics"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.708495\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T04:48:03Z","timestamp":1633322883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.708495\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":68,"alternative-id":["10.3389\/fmed.2021.708495"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.708495","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"article-number":"708495"}}